Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
Title:
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
Author:
Dodick, David W Goadsby, Peter J Silberstein, Stephen D Lipton, Richard B Olesen, Jes Ashina, Messoud Wilks, Kerri Kudrow, David Kroll, Robin Kohrman, Bruce Bargar, Robert Hirman, Joe Smith, Jeff